Sio Capital Management, LLC - Q4 2020 holdings

$489 Million is the total value of Sio Capital Management, LLC's 89 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 56.2% .

 Value Shares↓ Weighting
CRIS SellCURIS INC$38,955,000
+572.6%
4,756,438
-3.9%
7.97%
+595.2%
CVM BuyCEL-SCI CORPput$24,726,000
+62.2%
2,120,600
+77.4%
5.06%
+67.6%
GLD SellSPDR GOLD SHARES$18,284,000
-19.5%
102,509
-20.0%
3.74%
-16.7%
SPRB NewSPRUCE BIOSCIENCES INC$15,477,000636,653
+100.0%
3.17%
CHRS SellCOHERUS BIOSCIENCES INC$15,017,000
-21.6%
864,056
-17.2%
3.07%
-18.9%
ALBO SellALBIREO PHARMA INC$13,286,000
-16.8%
354,210
-26.0%
2.72%
-14.0%
HCA SellHCA HEALTHCARE INC$13,279,000
+0.5%
80,745
-23.8%
2.72%
+3.9%
AZN NewASTRAZENECA PLCsponsored adr$13,147,000263,000
+100.0%
2.69%
CI SellCIGNA CORP$12,962,000
-6.0%
62,265
-23.5%
2.65%
-2.9%
ABC SellAMERISOURCEBERGEN CORP$12,492,000
-21.3%
127,781
-22.0%
2.56%
-18.7%
WBA BuyWALGREENS BOOTS ALLIANCE INC$12,310,000
+14.2%
308,686
+2.9%
2.52%
+18.1%
HRC SellHILL-ROM HOLDINGS INC$12,070,000
-27.7%
123,198
-38.4%
2.47%
-25.3%
UHS NewUNIVERSAL HEALTH SERVICES INCcl b$11,116,00080,843
+100.0%
2.28%
SNY NewSANOFI SAsponsored adr$10,700,000220,201
+100.0%
2.19%
AMGN NewAMGEN INC$9,197,00040,000
+100.0%
1.88%
AMN SellAMN HEALTHCARE SERVICES INC$8,913,000
-44.0%
130,598
-52.0%
1.82%
-42.1%
BMRN SellBIOMARIN PHARMACEUTICAL INC$8,843,000
-40.3%
100,844
-48.2%
1.81%
-38.3%
MIRM NewMIRUM PHARMACEUTICALS INC$8,638,000494,743
+100.0%
1.77%
CAH SellCARDINAL HEALTH INC$8,313,000
-45.1%
155,217
-51.9%
1.70%
-43.2%
MCK SellMCKESSON CORP$8,255,000
-53.2%
47,462
-59.9%
1.69%
-51.6%
HZNP SellHORIZON THERAPEUTICS PLC$7,235,000
-36.9%
98,901
-32.9%
1.48%
-34.7%
BDX BuyBECTON DICKINSON AND CO$6,835,000
+77.3%
27,314
+64.8%
1.40%
+83.1%
TEVA SellTEVA PHARMACEUTICAL INDUSTRIES LTDsponsored ads$6,662,000
-22.3%
690,386
-27.5%
1.36%
-19.7%
SOLY SellSOLITON INC$6,623,000
-15.4%
862,405
-15.9%
1.36%
-12.6%
VRTX NewVERTEX PHARMACEUTICALS INC$6,192,00026,200
+100.0%
1.27%
OFIX SellORTHOFIX MEDICAL INC$5,954,000
-12.3%
138,525
-36.4%
1.22%
-9.3%
UTHR SellUNITED THERAPEUTICS CORP$5,879,000
-1.7%
38,734
-34.6%
1.20%
+1.6%
ASGN NewASGN INC$5,269,00063,077
+100.0%
1.08%
RDUS SellRADIUS HEALTH INC$5,236,000
-33.5%
293,157
-57.8%
1.07%
-31.3%
EPIX SellESSA PHARMA INC$5,166,000
+14.1%
433,023
-34.0%
1.06%
+18.0%
MRSN SellMERSANA THERAPEUTICS INC$4,922,000
-9.4%
184,959
-36.6%
1.01%
-6.3%
CLRB BuyCELLECTAR BIOSCIENCES INC$4,849,000
+186.6%
2,331,123
+70.8%
0.99%
+196.4%
IONS NewIONIS PHARMACEUTICALS INC$4,581,00081,026
+100.0%
0.94%
ARDX SellARDELYX INC$4,460,000
+12.6%
689,321
-8.6%
0.91%
+16.5%
VREX BuyVAREX IMAGING CORP$4,449,000
+203.1%
266,740
+131.2%
0.91%
+213.1%
ARNA SellARENA PHARMACEUTICALS INC$4,436,000
-17.3%
57,738
-19.5%
0.91%
-14.6%
SYNH SellSYNEOS HEALTH INCcl a$4,428,000
-25.2%
65,000
-41.6%
0.91%
-22.6%
KURA BuyKURA ONCOLOGY INC$4,320,000
+350.5%
132,283
+322.9%
0.88%
+365.3%
CCRN BuyCROSS COUNTRY HEALTHCARE INC$4,303,000
+65.2%
485,164
+20.9%
0.88%
+70.7%
CHAQU  CHARDAN HEALTHCARE ACQUISITION 2 CORPunit$4,236,000
+0.4%
400,0000.0%0.87%
+3.7%
LRMR SellLARIMAR THERAPEUTICS INC$4,039,000
-11.4%
188,661
-37.2%
0.83%
-8.4%
MOH SellMOLINA HEALTHCARE INC$3,991,000
-66.8%
18,763
-71.5%
0.82%
-65.7%
GWPH BuyGW PHARMACEUTICALS PLCads$3,901,000
+95.4%
33,801
+64.9%
0.80%
+102.3%
ITGR SellINTEGER HOLDINGS CORP$3,791,000
-50.3%
46,699
-63.9%
0.78%
-48.7%
SNDX BuySYNDAX PHARMACEUTICALS INC$3,784,000
+5229.6%
170,142
+3447.6%
0.78%
+5435.7%
NTUS BuyNATUS MEDICAL INC$3,744,000
+110.5%
186,833
+79.9%
0.77%
+117.6%
HLF SellHERBALIFE NUTRITION LTD$3,732,000
-9.7%
77,660
-12.3%
0.76%
-6.6%
MED NewMEDIFAST INCput$3,573,00018,200
+100.0%
0.73%
MESO SellMESOBLAST LTDput$3,543,000
-87.8%
417,300
-73.3%
0.72%
-87.4%
VKTX SellVIKING THERAPEUTICS INC$3,433,000
-16.9%
609,780
-14.1%
0.70%
-14.1%
CBAY SellCYMABAY THERAPEUTICS INC$3,371,000
-59.8%
587,339
-49.3%
0.69%
-58.5%
HSAQ  HEALTH SCIENCES ACQUISITIONS CORPORATION 2$3,203,000
+16.5%
250,0000.0%0.66%
+20.4%
EUCRU NewEUCRATES BIOMEDICAL ACQUISITION CORP.unit 10/23/2027$3,198,000300,000
+100.0%
0.66%
VINC NewVINCERX PHARMA INC$3,134,000149,892
+100.0%
0.64%
VRAY SellVIEWRAY INC$2,961,000
-58.5%
775,000
-62.0%
0.61%
-57.1%
ANIK SellANIKA THERAPEUTICS INC$2,959,000
-11.1%
65,382
-30.5%
0.61%
-8.0%
CRDF NewCARDIFF ONCOLOGY INC$2,695,000149,833
+100.0%
0.55%
CNST NewCONSTELLATION PHARMACEUTICALS INC$2,664,00092,500
+100.0%
0.54%
DTIL SellPRECISION BIOSCIENCES INC$2,649,000
+20.8%
317,644
-10.8%
0.54%
+24.9%
ASLN BuyASLAN PHARMACEUTICALS LTDads$2,549,000
-2.6%
1,392,654
+1.1%
0.52%
+0.8%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$2,506,00054,000
+100.0%
0.51%
SIOX NewSIO GENE THERAPIES INC$2,465,000886,665
+100.0%
0.50%
CERC SellCERECOR INC$2,449,000
+4.4%
927,746
-10.0%
0.50%
+8.0%
OTRK NewONTRAK INC$2,361,00038,218
+100.0%
0.48%
VAPO NewVAPOTHERM INC$2,087,00077,707
+100.0%
0.43%
BCEL BuyATRECA INC$2,075,000
+88.6%
128,455
+63.1%
0.42%
+95.0%
NBSE SellNEUBASE THERAPEUTICS INC$2,053,000
-11.1%
293,699
-3.5%
0.42%
-8.1%
FUSN NewFUSION PHARMACEUTICALS INC$2,029,000172,693
+100.0%
0.42%
AYLA SellAYALA PHARMACEUTICALS INC$1,723,000
-6.5%
156,655
-2.1%
0.35%
-3.3%
FULC NewFULCRUM THERAPEUTICS INC$1,713,000146,272
+100.0%
0.35%
ONCT NewONCTERNAL THERAPEUTICS INC$1,584,000323,333
+100.0%
0.32%
AGIO SellAGIOS PHARMACEUTICALS INC$1,517,000
-22.6%
35,000
-37.5%
0.31%
-19.8%
SLRX NewSALARIUS PHARMACEUTICALS INC$1,508,0001,657,242
+100.0%
0.31%
AGLE SellAEGLEA BIOTHERAPEUTICS INC$1,504,000
+0.5%
191,104
-9.5%
0.31%
+4.1%
ODT SellODONATE THERAPEUTICS INC$1,450,000
-20.0%
75,500
-44.1%
0.30%
-17.3%
HROW SellHARROW HEALTH INC$1,438,000
+7.8%
209,623
-12.2%
0.29%
+11.4%
CBIO SellCATALYST BIOSCIENCES INC$1,191,000
+39.5%
188,714
-5.0%
0.24%
+44.4%
MEIP SellMEI PHARMA INC$1,125,000
-19.5%
426,047
-4.9%
0.23%
-17.0%
SRRA NewSIERRA ONCOLOGY INC$1,065,00066,455
+100.0%
0.22%
AHACU  ALPHA HEALTHCARE ACQUISITION CORPunit 09/21/2027$1,057,000
+6.6%
100,0000.0%0.22%
+10.2%
DFHTU  DEERFIELD HEALTHCARE TECHNOLOGY ACQUISITIONS CORPunit 07/16/2025$750,000
+41.0%
50,0000.0%0.15%
+46.7%
IMAB  I-MABsponsored ads$707,000
+0.3%
15,0000.0%0.14%
+3.6%
VINCW NewVINCERX PHARMA INC*w exp 12/24/2025$693,000210,000
+100.0%
0.14%
IDYA SellIDEAYA BIOSCIENCES INC$676,000
-2.2%
48,298
-12.2%
0.14%
+0.7%
CASI SellCASI PHARMACEUTICALS INC$600,000
+74.4%
203,432
-9.6%
0.12%
+80.9%
NLTX  NEOLEUKIN THERAPEUTICS INC$540,000
+17.4%
38,3120.0%0.11%
+22.0%
RAPT  RAPT THERAPEUTICS INC$282,000
-38.7%
14,2980.0%0.06%
-36.3%
NewTRILLIUM THERAPEUTICS INC$228,00015,500
+100.0%
0.05%
ZSAN SellZOSANO PHARMA CORP$225,000
-69.3%
427,542
-5.5%
0.05%
-68.3%
PMVP ExitPMV PHARMACEUTICALS INC$0-1,000
-100.0%
-0.01%
GDRX ExitGOODRX HOLDINGS INC$0-1,000
-100.0%
-0.01%
MYOV ExitMYOVANT SCIENCES LTD$0-10,100
-100.0%
-0.03%
BNGO ExitBIONANO GENOMICS INC$0-268,096
-100.0%
-0.03%
PANAU ExitPANACEA ACQUISITION CORPunit$0-15,000
-100.0%
-0.04%
CRBP ExitCORBUS PHARMACEUTICALS HOLDINGS INCput$0-556,000
-100.0%
-0.20%
SYRS ExitSYROS PHARMACEUTICALS INC$0-166,780
-100.0%
-0.29%
DYAI ExitDYADIC INTERNATIONAL INC$0-209,064
-100.0%
-0.31%
ATNM ExitACTINIUM PHARMACEUTICALS INC$0-189,062
-100.0%
-0.36%
VNDA ExitVANDA PHARMACEUTICALS INC$0-209,205
-100.0%
-0.40%
OYST ExitOYSTER POINT PHARMA INC$0-105,803
-100.0%
-0.44%
ESPR ExitESPERION THERAPEUTICS INC$0-61,600
-100.0%
-0.45%
LSACU ExitLIFESCI ACQUISITION CORPunit 03/31/2025$0-210,000
-100.0%
-0.57%
LPTX ExitLEAP THERAPEUTICS INC$0-1,451,998
-100.0%
-0.57%
AFMD ExitAFFIMED NV$0-911,279
-100.0%
-0.61%
RDNT ExitRADNET INC$0-223,561
-100.0%
-0.68%
MDT ExitMEDTRONIC PLC$0-39,000
-100.0%
-0.80%
QTRX ExitQUANTERIX CORP$0-124,609
-100.0%
-0.83%
ANTM ExitANTHEM INC$0-16,031
-100.0%
-0.85%
CSII ExitCARDIOVASCULAR SYSTEMS INC$0-124,808
-100.0%
-0.97%
KOD ExitKODIAK SCIENCES INC$0-92,150
-100.0%
-1.08%
GSK ExitGLAXOSMITHKLINE PLCsponsored adr$0-206,638
-100.0%
-1.54%
DGX ExitQUEST DIAGNOSTICS INC$0-75,000
-100.0%
-1.70%
MCRB ExitSERES THERAPEUTICS INCput$0-316,800
-100.0%
-1.78%
JNJ ExitJOHNSON & JOHNSON$0-114,400
-100.0%
-3.37%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VIKING THERAPEUTICS INC24Q3 20233.4%
UNITED THERAPEUTICS ORD23Q3 20238.3%
CARDINAL HEALTH ORD20Q2 20227.2%
SANOFI SA19Q3 20229.8%
MEDTRONIC PLC18Q3 20235.2%
CATALYST BIOSCIENCES INC18Q3 202117.8%
PFENEX ORD18Q4 20195.9%
AEGLEA BIOTHERAPEUTICS INC18Q1 20231.1%
HCA HEALTHCARE INC17Q2 20225.5%
MCKESSON ORD17Q1 20226.0%

View Sio Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Sio Capital Management, LLC Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Modular Medical, Inc.February 13, 20231,091,47910.0%
Cellectar Biosciences, Inc.February 10, 2022? ?
CURIS INCFebruary 10, 20223,866,6454.2%
Salarius Pharmaceuticals, Inc.February 10, 20221,354,2913.0%
Larimar Therapeutics, Inc.February 16, 2021188,6611.2%
ACHIEVE LIFE SCIENCES, INC.February 14, 2020? ?
Bionano Genomics, IncFebruary 14, 20201,210,8214.6%
Brickell Biotech, Inc.February 14, 2020? ?
Trillium Therapeutics Inc.February 14, 20202,751,1869.8%
ZAFGEN, INC.February 14, 20202,283,1646.1%

View Sio Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
SC 13G2023-02-13
13F-HR2022-11-14

View Sio Capital Management, LLC's complete filings history.

Compare quarters

Export Sio Capital Management, LLC's holdings